25th week of 2021 patent applcation highlights part 12 |
Patent application number | Title | Published |
20210186975 | NURR1:RXR ACTIVATING COMPOUNDS FOR SIMULTANEOUS TREATMENT OF SYMPTOMS AND PATHOLOGY OF PARKINSON'S DISEASE | 2021-06-24 |
20210186976 | METHODS AND COMPOSITIONS FOR TREATMENT OF ZIKA VIRUS INFECTION | 2021-06-24 |
20210186977 | MEDICAL USES | 2021-06-24 |
20210186978 | COMBINATION THERAPY | 2021-06-24 |
20210186979 | SMALL MOLECULE INHIBITORS OF CDK12/CDK13 | 2021-06-24 |
20210186980 | COMPOSITION FOR PREVENTION OR TREATMENT OF INTRACTABLE EPILEPSY COMPRISING mTOR INHIBITOR | 2021-06-24 |
20210186981 | METHODS OF USE OF EMULSION FORMULATIONS OF APREPITANT | 2021-06-24 |
20210186982 | METHODS AND COMPOSITIONS FOR TREATING MELANOMA | 2021-06-24 |
20210186983 | ORALLY ADMINISTERED COMBINATIONS OF AMOXICILLIN AND AVIBACTAM DERIVATIVES FOR TREATING MYCOBACTERIAL INFECTIONS | 2021-06-24 |
20210186984 | CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING ANCA ASSOCIATED VASCULITIDES | 2021-06-24 |
20210186985 | METHODS FOR TREATING DISEASES ASSOCIATED WITH CILIOPATHIES | 2021-06-24 |
20210186986 | USES OF CELASTROL IN PREVENTING AND/OR TREATING CHOLESTATIC LIVER DISEASE AND LIVER FIBROSIS | 2021-06-24 |
20210186987 | GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS | 2021-06-24 |
20210186988 | PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | 2021-06-24 |
20210186989 | ENHANCED TRAINED IMMUNITY IN MYELOID CELLS BY SHIP-1 INHIBITION | 2021-06-24 |
20210186990 | METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS | 2021-06-24 |
20210186991 | TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS | 2021-06-24 |
20210186992 | METHOD AND COMPOSITIONS FOR THE TREATMENT OF ANEMIA THROUGH THE INHIBITION OF FURIN | 2021-06-24 |
20210186993 | COMBINATION THERAPIES TARGETING MITOCHONDRIA FOR CANCER THERAPY | 2021-06-24 |
20210186994 | Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpi- perazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine | 2021-06-24 |
20210186995 | PLASMALOGEN-CONTAINING COMPOSITION | 2021-06-24 |
20210186996 | METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS | 2021-06-24 |
20210186997 | METHODS AND COMPOSITIONS FOR INCREASING NAD LEVEL IN MAMMALS WITH D-RIBOSE AND VITAMIN B3 | 2021-06-24 |
20210186998 | COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS | 2021-06-24 |
20210186999 | METHOD FOR TREATMENT OF CANCER | 2021-06-24 |
20210187000 | METHODS FOR TREATING DEGENERATIVE DISC DISEASE AND CHRONIC LOWER BACK PAIN | 2021-06-24 |
20210187001 | Compositions and Devices for Systemic Delivery of Uridine | 2021-06-24 |
20210187002 | ANTIMALARIAL DRUG, MALARIA TREATMENT METHOD, SCREENING METHOD FOR CANDIDATE SUBSTANCE FOR MALARIA TREATMENT, MALARIA SEVERITY MARKER, METHOD FOR TESTING RISK OF SEVERE MALARIA, AND TEST REAGENT | 2021-06-24 |
20210187003 | EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY | 2021-06-24 |
20210187004 | DEFIBROTIDE FOR THE PREVENTION AND TREATMENT OF CYTOKINE RELEASE SYNDROME AND NEUROTOXICITY ASSOCIATED WITH IMMUNODEPLETION | 2021-06-24 |
20210187005 | PHARMACEUTICAL COMPOSITION | 2021-06-24 |
20210187006 | TALEN-BASED GENE CORRECTION | 2021-06-24 |
20210187007 | C/EBP ALPHA SARNA COMPOSITIONS AND METHODS OF USE | 2021-06-24 |
20210187008 | USE OF ACANTHOPANAX TRIFOLIATUS POLYSACCHARIDE ATP1-1 IN PREPARATION OF DRUGS FOR TREATMENT OF DIABETES | 2021-06-24 |
20210187009 | Use of Polysaccharide for Treating ST-Elevation Myocardial Infarction and Diseases of the Digestion System | 2021-06-24 |
20210187010 | POLYMER LUNG SURFACTANTS | 2021-06-24 |
20210187011 | METHOD OF TREATING ACID-BASE DISORDERS | 2021-06-24 |
20210187012 | ANTI-COAGULANT AGENT, ANTICOAGULATION DEVICE, BLOOD COAGULATION CURING METHOD, VASCULAR ENDOTHELIAL CELL FUNCTION IMPROVING METHOD, AND METABOLISM IMPROVING METHOD | 2021-06-24 |
20210187013 | Methods of Treating and Preventing Cancer by Disrupting the Binding of Copper in the Map Kinase Pathway | 2021-06-24 |
20210187014 | Methods, Systems And Compositions For The Novel Use of Enterobactin to Treat Iron Deficiency And Related Anemia And Promote Red Blood Cell Production | 2021-06-24 |
20210187015 | COMPOSITION AND METHOD FOR THE PREVENTION AND TREATMENT OF TYPE 2 DIABETES | 2021-06-24 |
20210187016 | METHOD OF TREATING NONALCOHOLIC STEATOHEPATITIS | 2021-06-24 |
20210187017 | COMPOSITION AND METHOD FOR THE PREVENTION AND TREATMENT OF OBESITY | 2021-06-24 |
20210187018 | CYTOBIOLOGICS AND THERAPEUTIC USES THEREOF | 2021-06-24 |
20210187019 | FOOD FACTOR-BASED FORMULATION, PRODUCTS PRODUCED USING SAID FORMULATION AND METHODS FOR PRODUCING SAME | 2021-06-24 |
20210187020 | PLASMA COMPOSITIONS AND METHODS OF USE THEREOF | 2021-06-24 |
20210187021 | SYSTEM AND METHOD FOR INDUCING APOPTOSIS IN CANCER CELLS BY DEGRADATION OF HISTONE RNA | 2021-06-24 |
20210187022 | ENGINEERED T CELLS FOR THE TREATMENT OF CANCER | 2021-06-24 |
20210187023 | Compositions And Methods For Enhancing Immunotherapy | 2021-06-24 |
20210187024 | NK-92 Cells to Stimulate Anti-Cancer Vaccine | 2021-06-24 |
20210187025 | SUBSETS OF HUMAN NATURAL KILLER CELLS WITH ENHANCED ANTIBODY-DIRECTED IMMUNE RESPONSES | 2021-06-24 |
20210187026 | CELL | 2021-06-24 |
20210187027 | NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF | 2021-06-24 |
20210187028 | POLYCLONAL GAMMA DELTA T CELLS FOR IMMUNOTHERAPY | 2021-06-24 |
20210187029 | EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES (TILS) WITH TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY (TNFRSF) AGONISTS AND THERAPEUTIC COMBINATIONS OF TILS AND TNFRSF AGONISTS | 2021-06-24 |
20210187030 | In Vivo Genetic Engineering of Antigen Responsive Cells | 2021-06-24 |
20210187031 | TRANSPLANT MATERIAL FOR TREATMENT OF HEART DISEASE | 2021-06-24 |
20210187032 | METHODS AND COMPOSITIONS RELATED TO EXTRACELLULAR MATERIAL DERIVED FROM HYPERTONIC CELL SOLUTIONS | 2021-06-24 |
20210187033 | COMPOUNDS THAT EXPAND HEMATOPOIETIC STEM CELLS | 2021-06-24 |
20210187034 | PROCESSES FOR MAKING AND USING A MESENCHYMAL STEM CELL DERIVED SECRETOME | 2021-06-24 |
20210187035 | COMPOSITION CONTAINING, AS ACTIVE INGREDIENT, CULTURE OF CHICKEN BONE MARROW-DERIVED OSTEOCHONDRAL PROGENITOR CELLS FOR PROMOTING OSTEOGENESIS OR INDUCING CHONDROGENIC DIFFERENTIATION | 2021-06-24 |
20210187036 | Method of Tissue Repair | 2021-06-24 |
20210187037 | FETAL TISSUE EXTRACT, METHODS FOR PRODUCING THE SAME, AND THE USES THEREOF | 2021-06-24 |
20210187038 | CARDIAC STEM CELLS FOR CARDIAC REPAIR | 2021-06-24 |
20210187039 | FECAL PROCESSING DEVICE AND METHODS | 2021-06-24 |
20210187040 | IPSC-DERIVED SECRETOME COMPOSITIONS, AND RELATED SYSTEMS AND METHODS | 2021-06-24 |
20210187041 | NERVE GROWTH PROMOTER AND METHOD FOR PRODUCING SAME, INTERNAL PREPARATION, MEDIUM ADDITIVE, CELL DILUTION ADDITIVE, MEDIUM, CELL DILUTION, ANTIOXIDANT AND METHOD FOR PRODUCING SAME, EXTERNAL PREPARATION, AND WOUND TREATMENT AGENT AND METHOD FOR PRODUCING SAME | 2021-06-24 |
20210187042 | MOLECULES DERIVED FROM GRAM-POSITIVE BACTERIA | 2021-06-24 |
20210187043 | METHODS AND COMPOSITIONS FOR CHANGING THE COMPOSITION OF THE SKIN MICROBIOME USING COMPLEX MIXTURES OF BACTERIAL STRAINS | 2021-06-24 |
20210187044 | LACTIC ACID BACTERIA CAPABLE OF CONTROLLING BLOOD SUGAR AND USE THEREOF | 2021-06-24 |
20210187045 | AQUEOUS LIQUID EXTRACT OF SPIRULINA FOR PREVENTING OR TREATING LIPIDO-CARBOHYDRATE METABOLISM DISORDERS | 2021-06-24 |
20210187046 | COCKTAIL COMPOSITIONS COMPRISING RESPIRATORY ANTIBACTERIAL PHAGES AND METHODS OF USE THEREOF | 2021-06-24 |
20210187047 | ONCOLYTIC ADENOVIRUSES ARMED WITH HETEROLOGOUS GENES | 2021-06-24 |
20210187048 | ONCOLYTIC RHABDOVIRUS | 2021-06-24 |
20210187049 | PURIFIED COMPOSITIONS OF ENTEROVIRUSES AND METHODS OF PURIFICATION WITH GLUTATHIONE AFFINITY CHROMATOGRAPHY | 2021-06-24 |
20210187051 | PIPER LAETISPICUM EXTRACT AND PREPARATION METHOD THEREFOR AND USE THEREOF | 2021-06-24 |
20210187052 | Therapeutic Use Of Grape Seed Products | 2021-06-24 |
20210187053 | COMPOUND FOR TREATING OXIDATIVE STRESS IN MAMMALS | 2021-06-24 |
20210187054 | EFFICACY OF AN ANTI-C5 ANTIBODY IN THE PREVENTION OF ANTIBODY MEDIATED REJECTION IN SENSITIZED RECIPIENTS OF KIDNEY TRANSPLANT | 2021-06-24 |
20210187055 | LISINOPRIL FORMULATIONS | 2021-06-24 |
20210187056 | METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE | 2021-06-24 |
20210187057 | Methods and Compositions for Use of a Chemokine Receptor Antagonist Peptide to Treat Addiction, Substance Abuse Disorders or Symptoms Thereof | 2021-06-24 |
20210187058 | METHODS FOR ADMINISTERING ANGIOTENSIN II | 2021-06-24 |
20210187059 | PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER | 2021-06-24 |
20210187060 | METHOD OF TREATING OPHTHALMIC CONDITIONS | 2021-06-24 |
20210187061 | NOVEL ENTERIC COMBINATION THERAPY | 2021-06-24 |
20210187062 | PEPTIDES HAVING SPECIFICITY FOR THE LUNGS | 2021-06-24 |
20210187063 | TREATMENT METHODS USING BOTULINUM TOXINS | 2021-06-24 |
20210187064 | MUTATED E. COLI ENTEROTOXINS AS ANTI-INFLAMMATORY AGENTS | 2021-06-24 |
20210187065 | PHARMACEUTICAL COMPOSITION FOR TREATING RETINAL DYSTROPHIES, COMPRISING NKX3.2 AND FRAGMENT THEREOF AS ACTIVE INGREDIENTS | 2021-06-24 |
20210187066 | Formulated and/or co-formulated liposome compositions containing toll-like receptor ("TLR") agonist prodrugs useful in the treatment of cancer and methods thereof | 2021-06-24 |
20210187067 | TREATMENT OF DISEASES INVOLVING DEFICIENCY OF ENPP1 OR ENPP3 | 2021-06-24 |
20210187068 | Lipopolysaccharide-Binding Protein For Use In A Method Of Treating Alzheimer's Disease | 2021-06-24 |
20210187069 | DOMINANT NEGATIVE SARM1 MOLECULES AS A THERAPEUTIC STRATEGY FOR NEURODEGENERATIVE DISEASES OR DISORDERS | 2021-06-24 |
20210187070 | ELECTRICAL STIMULATION OF CELLS TO INDUCE ENHANCED SECRETOME FOR THERAPEUTIC APPLICATIONS | 2021-06-24 |
20210187071 | COMPOSITIONS COMPRISING MDA-7/IL-24 PROTEIN AND METHODS OF USE | 2021-06-24 |
20210187072 | METHODS AND COMPOSITIONS FOR REDUCING RISK OF RELAPSE AND PROLONGING SURVIVAL IN ACUTE MYELOID LEUKEMIA | 2021-06-24 |
20210187073 | TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA | 2021-06-24 |
20210187074 | TREATMENT OF BILIARY CIRRHOSIS BASED ON OXYNTOMODULIN ANALOGUE GLP-1R/GCGR DUAL-TARGET AGONIST PEPTIDE | 2021-06-24 |
20210187075 | TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS | 2021-06-24 |